Opinion

Video

Moving Beyond The Joint: Unraveling Gout's Systemic and Renal Implications

Key opinion leaders analyze EULAR 2024 updates on gout, chronic inflammation's systemic impact, and gout-chronic kidney disease (CKD) connections, while examining urate-lowering therapies for gout management, particularly in patients with CKD.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Steven Fein, MD | Credit: University of Michigan
Related Content
Iain B. McInnes, MBChB I Credit: University of Glasgow
December 21st 2024

Guselkumab 100 mg Every 8 Weeks Consistently Improves Joint, Skin Through Week 24

Chelsie Derman
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor
December 16th 2024

Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision | HCPLive.com
December 21st 2024

Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision

Isabella Ciccone, MPH
Irl Hirsch, MD | Credit: University of Washington
December 12th 2024

Diabetes Dialogue: Celebrating 25 Years of CGM, with Irl Hirsch, MD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
FDA Approves Tirzepatide for Obstructive Sleep Apnea in Obesity | Image Credit: US Food and Drug Administration
December 20th 2024

FDA Approves Tirzepatide for Obstructive Sleep Apnea in Obesity

Connor Iapoce
FDA logo in black over a white background. | Credit: US Food and Drug Administration
December 20th 2024

FDA Issues CRL for Sotagliflozin in Type 1 Diabetes and CKD

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.